On Monday, the benchmark indices were trading higher with the Sensex up around 940 points or 1.4% at 68,420 while the Nifty-50 up around 298 points or 1.47% at 20,565. About 2,518 shares have advanced, 1,132 declined, and 197 are unchanged on the BSE. Top gainers and losers on the BSE Sensex index are as …
With wedding season rapidly coming, the next few weeks are projected to witness an increase in demand, making it an ideal opportunity for investors to explore investing in relevant businesses and sectors. According to a CAIT poll, about 35 lakh weddings are projected to take place across the country between November 23 and December 15, …
In the dynamic landscape of the Indian automotive industry, Mahindra & Mahindra (M&M) and Tata Motors emerge as key contenders, each navigating distinct paths in response to market challenges and opportunities. November 2023 witnessed contrasting sales performances, with M&M boasting a 32% surge in SUV sales while Tata Motors resiliently held ground amidst a marginal …
These 3 stocks have shown good chemistry with 50-day EMA in the last few trading sessions, indicating strong bullish activity. Here’s an in-depth look. EMA Bounce Back Strategy The 50-day EMA bounce strategy is based on the idea that a stock price that retraces to its 50-day EMA and then bounces off of it may …
The Nifty50 commenced the day with a bullish gap-up opening at 20,194.10, signalling a strong upward momentum that has persisted for the past three trading sessions. Following a breakout from the November 16 trading session high, the Nifty has been on a sustained upward trajectory. It managed to retain its gains from the first half …
Today, the broader indices, namely NSE Nifty50 and BSE Sensex, ended the day in the green. The Nifty50 index commenced trading at 20,194 and eventually concluded at 20,267.90, marking a gain of 134.75 points or 0.67% compared to the previous day’s closing level of 20,133. Meanwhile, the BSE Sensex concluded at 67,481 showing a positive …
USDFA approval for Ivabradine Tablets Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Ivabradine Tablets, 5 mg and 7.5 mg (USRLD: Corlanor Tablets, 5 mg and 7.5 mg). Ivabradine is indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic …
Today, the broader indices, namely NSE Nifty50 and BSE Sensex, ended the day in the green. The Nifty50 index commenced trading at 19,977 and eventually concluded at 20,097, marking a gain of 207 points or 1.04% compared to yesterday’s closing level of 19,890. Meanwhile, the BSE Sensex concluded at 66,902, showing a positive trend. Among …
Market Update The Sensex is showcasing a rise of 0.79%, and the Nifty is experiencing an uptick of 0.73%. This positive momentum extends to the broader market, where the Nifty Midcap has marked a significant 1.16% increase, and the Nifty Smallcap has registered a 0.69% uptick. Top performers in the market include Nifty Media, Nifty …
In the financial years spanning from 2020 to 2023, Indian companies, including those listed in the Nifty 50 have demonstrated impressive resilience and recovery in their corporate earnings. Notably, the net profit for Nifty 50 witnessed a substantial compound annual growth rate (CAGR) of 22%. Looking forward to the fiscal year 2025, projected growth of …
